quinazolines has been researched along with Polyuria in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
KOZMA, JJ | 1 |
Keshavan, V; Shanthi, M; Tyagi, MG; Vikram, GS | 1 |
Agnoli, GC; Borgatti, R; Cacciari, M; Dorigoni, S; Garutti, C; Ikonomu, E; Lenzi, P | 1 |
3 other study(ies) available for quinazolines and Polyuria
Article | Year |
---|---|
CLINICAL EVALUATION OF QUINETHAZONE-RESERPINE COMBINATION IN HYPERTENSION.
Topics: Antihypertensive Agents; Biomedical Research; Candidiasis, Oral; Diabetes Mellitus; Diuretics; Drug Therapy; Gout; Headache; Hypertension; Hypotension; Hypotension, Orthostatic; Polyuria; Quinazolines; Reserpine; Sulfonamides; Toxicology; Xerostomia | 1964 |
Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Heart Rate; Injections, Intraperitoneal; Injections, Intravenous; Lithium Carbonate; Lypressin; Mice; Motor Activity; Neomycin; Phospholipids; Piperidines; Polyuria; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Sphingosine | 2004 |
[Low-dose dopamine as an activator of renal catecholamine receptors of different classes. II. Studies in water-saline depletion and associated adrenergic blockade].
Topics: Dopamine; Hemodynamics; Humans; Hyponatremia; Kidney; Natriuresis; Polyuria; Prazosin; Quinazolines; Receptors, Adrenergic, beta; Water Deprivation | 1984 |